News

Two 40 mg/kg doses given 3 hours apart are safe, well tolerated, and more effective in achieving parasitic cure than the current proposed single 40 mg/kg dose. Until a paediatric formulation of ...
Zydus has received final approval from the USFDA for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes.
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma Darrell White 1 Gary J. Schiller 2 Sumit Madan 3 ...
Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn medications Nexium ...
Pharma major AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn drug Prilosec in the ...
AstraZeneca has agreed to settle substantially all of the product liability litigation for its anti-acid medications, Nexium and Prilosec, paying $425M.
AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec.
Topline AstraZeneca has agreed to pay $425 million over 11,000 claims the heartburn drugs Nexium and Prilosec caused chronic kidney disease.
British drugmaker AstraZeneca on Tuesday said it will pay $425 million (€375 million) to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn ...
AstraZeneca agreed to make payment of $425 million, for which a provision has been taken. Nexium and Prilosec are prescription only drugs used to treat patients with acid-related symptoms and ...